fda import alert green list glp-1 semaglutide tirzepatide 2025 introduces "Green List" for drug ingredients | Bob Durkin posted on the topic FDA Demurs on GLP-1 Compounding

Q: Whats the difference between L-Carnitine and other horse energy supplements

Fonseca VA, Alvarado-Ruiz R, Raccah D, et al

Beyond their original design for diabetes and the notable side effect of losing significant amounts of weight, clinical trials have shown that GLP-1s reduce the risk of heart attacks, strokes, kidney disease progression, heart failure, and even COVID-19 mortality

Current clinical evidence suggests GLP-1 medications should be discontinued before conception and throughout pregnancy, though individual circumstances vary based on metabolic health and medical history

others prefer thigh injections because they can inject while seated and fully clothed

Retatrutide 2026: TRIUMPH-4 Phase 3 Shows 28.7% Weight Loss Breaking: First Phase 3 trial delivers unprecedented weight loss results Introduction December 11, 2025 marked a watershed moment in obesity medicine